CD40 and autoimmune disease: The interaction of the cell surface receptor CD40 and its ligand CD40L (CD154) is known to play a central role in the regulation of humoral and cellular immunity and in the pathogenesis of these autoimmune diseases [3, 4]; thus, targeting this interaction may be a therapeutic option.